High Court Considers Drug Sales Reps' OT Status


In an article on the U.S. Supreme Court oral arguments in Christopher v. SmithKline, Littler’s Tammy McCutchen provides perspective on the Justices’ line of questioning on whether a proposed class of reps is entitled to overtime pay. McCutchen, who filed an amicus brief in support of GlaxoSmithKline on behalf of the National Federation of Independent Business, notes that “there were no clear positions along political or philosophical lines.”

View Article (subscription required)